Clinical trial
ASPIrin in Reducing Events in Dialysis
NCT04381143 is registered in ClinicalTrials.gov with Guangdong Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ASPIrin in Reducing Events in Dialysis
- Lead sponsor
- Guangdong Provincial People's Hospital
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- July 30, 2020
- Completion date
- December 31, 2026
- Enrollment
- 9,082 (actual)
- Sites
- 127
Conditions
As the registry lists them; a condition with its own page is linked.
ckd (chronic kidney disease) stage 5d